CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.License Agreement • September 10th, 2021 • Pyxis Oncology, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledSeptember 10th, 2021 Company Industry JurisdictionTHIS FIRST AMENDMENT TO LICENSE AGREEMENT (this “Amendment”) is entered into as of 25th February, 2021, effective as of the Effective Date. Capitalized terms used but not defined herein shall have the meanings assigned to such terms in the Agreement (as defined below).
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. Execution CopyLicense Agreement • September 10th, 2021 • Pyxis Oncology, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledSeptember 10th, 2021 Company Industry Jurisdiction